MergerLinks - Alan Hippe

.

New Deal

New Deal

Cover Image Alan Hippe

Alan Hippe

CFO at ROCHE HOLDINGS AG

Manager

Deal Bio

Total Deals9

Valued Deals6

Total Value£27,003M

Avg. Deal Size£4,500M

Key Relationships

Pharmaceuticals

PublicMergerAcquisitionMajority

Spark Therapeutics

target

Spark Therapeutics

Roche Holdings

bidder

Roche Holdings

£3,291m

29 dealmakers

Medical Equipment

AcquisitionPrivateMajorityDisposal

Roche Health Solutions

target

Roche Health Solutions

Biotelemetry

bidder

Biotelemetry

value n/a

7 dealmakers

MajorityPublicCross BorderAcquisitionVenture CapitalPrivate Equity

INFLAZOME

target

INFLAZOME

Roche Holdings

bidder

Roche Holdings

£348m

16 dealmakers

Cross BorderMajorityPrivateAcquisition

Obi Medical Aps

target

Obi Medical Aps

Roche Holdings

bidder

Roche Holdings

value n/a

14 dealmakers

Medical Services

AcquisitionPublicTender OfferMajorityCross Border

Genmark Diagnostics

target

Genmark Diagnostics

Roche Holdings

bidder

Roche Holdings

£1,292m

33 dealmakers

AcquisitionPrivateCross BorderMajority

Tib Molbiol

target

Tib Molbiol

Roche Holdings

bidder

Roche Holdings

value n/a

41 dealmakers

Pharmaceuticals

DomesticPublicAcquisitionMajority

Novartis (roche Shares)

target

Novartis (roche Shares)

Roche Holdings

bidder

Roche Holdings

£15,166m

34 dealmakers

AcquisitionDomesticPrivateMajority

Telavant Holdings

target

Telavant Holdings

Roche Holdings

bidder

Roche Holdings

£5,960m

32 dealmakers

Pharmaceuticals

AcquisitionCross BorderMajorityPrivateInfrastructure

Roche Holdings (genentech Large-scale Biologics Manufacturing Site)

target

Roche Holdings (genentech Large-scale Biologics Manufacturing Site)

Lonza Group

bidder

Lonza Group

£944m

4 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.